Literature DB >> 33978482

Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty.

Liisa Hantsoo1, Husna Sajid2, Laura Murphy3, Brett Buchert3, Jordan Barone2, Sabina Raja2, Tory Eisenlohr-Moul2.   

Abstract

Background: Premenstrual dysphoric disorder (PMDD) is a severe mood disorder that affects ∼5% of menstruating individuals. Although symptoms are limited to the luteal phase of the menstrual cycle, PMDD causes significant distress and impairment across a range of activities. PMDD is under-recognized by health care providers, can be difficult to diagnose, and lies at the intersection of gynecology and psychiatry. Thus, many patients are misdiagnosed, or encounter challenges in seeking care. The aim of this study was to examine patients' experiences with different health care specialties when seeking care for PMDD symptoms.
Methods: We examined data from the 2018 Global Survey of Premenstrual Disorders conducted by the International Association for Premenstrual Disorders (IAPMD). Patients rated their health care providers (general practitioners, psychiatrists, gynecologists, psychotherapists) in three key areas related to treatment of premenstrual mood complaints: interpersonal factors, awareness and knowledge of PMDD, and whether the patient was asked to track symptoms daily. Intraclass correlations examined between- and within-person variance. Multilevel regression models predicted ratings on each provider competency item, with ratings nested within individuals to examine the within-patient effect of provider type on outcomes.
Results: The sample included 2,512 patients who reported seeking care for PMDD symptoms. Regarding interpersonal factors, psychotherapists were generally rated the highest. On awareness and knowledge of PMDD, gynecologists and psychiatrists were generally rated the highest. Gynecologists were more likely than other providers to ask patients to track symptoms daily. Conclusions: These findings suggest that different providers have different strengths in assessing and treating PMDD. Further, graduate and medical training programs may benefit from increased curricular development regarding evidence-based evaluation and treatment of PMDD.

Entities:  

Keywords:  PMDD; PMS; mental health services; premenstrual dysphoric disorder; premenstrual syndrome; primary care

Mesh:

Year:  2021        PMID: 33978482      PMCID: PMC8785767          DOI: 10.1089/jwh.2020.8797

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  36 in total

Review 1.  The etiology, biology, and evolving pathology of premenstrual syndromes.

Authors:  Uriel Halbreich
Journal:  Psychoneuroendocrinology       Date:  2003-08       Impact factor: 4.905

2.  Daily Record of Severity of Problems (DRSP): reliability and validity.

Authors:  J Endicott; J Nee; W Harrison
Journal:  Arch Womens Ment Health       Date:  2005-09-20       Impact factor: 3.633

3.  Does a disconnect occur between research and practice for premenstrual dysphoric disorder (PMDD) diagnostic procedures?

Authors:  Julia R Craner; Sandra T Sigmon; Morgan L McGillicuddy
Journal:  Women Health       Date:  2014

4.  Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities.

Authors:  Lothar A J Heinemann; Thai Do Minh; Klaas Heinemann; Marion Lindemann; Anna Filonenko
Journal:  Health Care Women Int       Date:  2012

Review 5.  Premenstrual Dysphoric Disorder: Epidemiology and Treatment.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

6.  Diagnosing and treating premenstrual syndrome in five western nations.

Authors:  George Weisz; Loes Knaapen
Journal:  Soc Sci Med       Date:  2009-02-21       Impact factor: 4.634

7.  Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome.

Authors:  W H Cronje; A Vashisht; J W W Studd
Journal:  Hum Reprod       Date:  2004-06-30       Impact factor: 6.918

8.  "One end has nothing to do with the other:" patient attitudes regarding help seeking intention for depression in gynecologic and obstetric settings.

Authors:  Ian M Bennett; Steven Palmer; Steven Marcus; James M Nicholson; Liisa Hantsoo; Scarlet Bellamy; Jessica Rinaldi; James C Coyne
Journal:  Arch Womens Ment Health       Date:  2009-10       Impact factor: 3.633

9.  Premenstrual Disorders: A Primer and Research Agenda for Psychologists.

Authors:  Tory Eisenlohr-Moul
Journal:  Clin Psychol       Date:  2019

10.  Women's experiences of receiving a diagnosis of premenstrual dysphoric disorder: a qualitative investigation.

Authors:  Elizabeth Osborn; Anja Wittkowski; Joanna Brooks; Paula E Briggs; P M Shaughn O'Brien
Journal:  BMC Womens Health       Date:  2020-10-28       Impact factor: 2.809

View more
  4 in total

Review 1.  Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps.

Authors:  Christine Kuehner; Sibel Nayman
Journal:  Curr Psychiatry Rep       Date:  2021-10-09       Impact factor: 5.285

2.  Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder.

Authors:  Tory Eisenlohr-Moul; Madeline Divine; Katja Schmalenberger; Laura Murphy; Brett Buchert; Melissa Wagner-Schuman; Alyssa Kania; Sabina Raja; Adam Bryant Miller; Jordan Barone; Jaclyn Ross
Journal:  BMC Psychiatry       Date:  2022-03-19       Impact factor: 4.144

3.  A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS).

Authors:  Benicio N Frey; Olivia R Allega; Maha Eltayebani; Sabrina K Syan; Jeronimo Mendes-Ribeiro; Luciano Minuzzi
Journal:  BMC Womens Health       Date:  2022-03-30       Impact factor: 2.809

4.  Premenstrual symptoms across the lifespan in an international sample: data from a mobile application.

Authors:  Liisa Hantsoo; Shivani Rangaswamy; Kristin Voegtline; Rodion Salimgaraev; Liudmila Zhaunova; Jennifer L Payne
Journal:  Arch Womens Ment Health       Date:  2022-08-26       Impact factor: 4.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.